Vestal Point Capital »

Kalvista Pharmaceuticals shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Kalvista Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $27M 2.3M 11.78

More positions owned by Vestal Point Capital

Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Ultragenyx Pharmaceutical (RARE)
Globus Medical Cl A (GMED)
Insmed Com Par $.01 (INSM)
BeiGene Sponsored Adr (BGNE)
Soleno Therapeutics (SLNO)
EXACT Sciences Corporation (EXAS)
Arcellx Common Stock (ACLX)
Immatics NV SHS (IMTX)
Janux Therapeutics (JANX)
Astria Therapeutics (ATXS)
Kalvista Pharmaceuticals (KALV)
Savara (SVRA)

View all positions for Vestal Point Capital

Top funds holding Kalvista Pharmaceuticals

VR Adviser
Tang Capital Management
Suvretta Capital Management
Frazier Life Sciences Management
BlackRock
Adage Capital Partners GP
Vestal Point Capital
Vanguard Group
Boxer Capital
Capital World Investors
Dr. Jeffrey R. Jay, M.D.
First Turn Management
Saturn V Capital Management
MPM Oncology Impact Management
DAFNA Capital Management

View all funds holding Kalvista Pharmaceuticals